oxidative stress | Akademické centrum výskumu autizmu

- 12. MAY 2022
Improvement of the Clinical and Psychological Profile of Patients with Autism after Methylcobalamin Syrup Administration
AUTHORS: Čorejová, A., Fazekaš, T., Jánošíková, D., Repiský, J., Pospíšilová, V., Miková, M., Rauová, D., Ostatníková, D., Kyselovič, J., Hrabovská, A. ABSTRACT: (1) Background: Autism, also known as autism-spectrum disorder, is a pervasive developmental disorder affecting social skills and psychological status in particular. The complex etiopathogenesis of autism limits efficient therapy, which leads to problems
Viac
- Barbara Rašková
- 2022,
- 2022,
- Publications
- Publications
- 14. JANUARY 2021
The acute effect of psychosocial stress on the level of oxidative stress in children
AUTHORS: Janšáková, K., Belica, I., Rajčániová, E., Rajčáni, J., Kyselicová, K., Celušáková, H., Laznibatová, J. and Ostatníková, D. ABSTRACT: The effect of chronic stress on oxidative stress (OS) is commonly discussed while the effect of acute stress situation is not fully examined yet. The present study was aimed to analyse whether acute psychosocial strain causes
Viac
- Barbara Rašková
- 2021,
- Publications
- 2. NOVEMBER 2020
A novel UHPLC-MS method targeting urinary metabolomic markers for autism spectrum disorder
AUTHORS: Olešová, D., Galba, J., Piešťanský, J., Celušáková, H., Repiská, G., Babinská, K., Ostatníková, D., Katina, S. and Kováč, A. ABSTRACT: Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed
Viac
- Barbara Rašková
- 2020,
- Publications
- 1. MAY 2020
A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder
AUTHORS: Olesova, D., Galba, J., Piestansky, J., Celusakova, H., Repiska, G., Babinska, K., Ostatnikova, D., Katina, S., Kovac, A.. ABSTRACT: Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed toViac

Archives

Improvement of the Clinical and Psychological Profile of Patients with Autism after Methylcobalamin Syrup Administration

The acute effect of psychosocial stress on the level of oxidative stress in children

A novel UHPLC-MS method targeting urinary metabolomic markers for autism spectrum disorder

A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder